Compounds > adamantane
Page last updated: 2024-08-21

adamantane and Allodynia

adamantane has been researched along with Allodynia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolik, LG; Konstantinopolsky, MA1
Barna, I; Király, K; Kozsurek, M; Lambeir, AM; Luyten, W; Puskár, Z; Rónai, AZ; Szalai, J; Szentirmay, A1
Bihel, F; Bockel, F; Bourguignon, JJ; Elhabazi, K; Maldonado, R; Meziane, H; Mollereau, C; Moulédous, L; Petit-demoulière, B; Schmitt, M; Simonin, F; Trigo, JM; Zajac, JM1
Bourguignon, JJ; Jhamandas, JH; Kieffer, BL; Laboureyras, E; Laulin, JP; Laurent, P; MacTavish, D; Matifas, A; Mollereau, C; Parmentier, M; Schmitt, M; Simonin, F; Simonnet, G1

Other Studies

4 other study(ies) available for adamantane and Allodynia

ArticleYear
Comparative Assessment of the Effectiveness of Noncompetitive NMDA Receptor Antagonists Amantadine and Hemantane in Morphine Withdrawal Syndrome Model.
    Bulletin of experimental biology and medicine, 2019, Volume: 166, Issue:6

    Topics: Adamantane; Amantadine; Animals; Gene Expression; Hyperalgesia; Injections, Intraperitoneal; Male; Morphine; Morphine Dependence; Motor Activity; Narcotic Antagonists; Rats; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Weight Loss

2019
The dipeptidyl peptidase IV (CD26, EC 3.4.14.5) inhibitor vildagliptin is a potent antihyperalgesic in rats by promoting endomorphin-2 generation in the spinal cord.
    European journal of pharmacology, 2011, Jan-10, Volume: 650, Issue:1

    Topics: Adamantane; Animals; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Spinal; Injections, Subcutaneous; Male; Nitriles; Oligopeptides; Pyrrolidines; Rats; Rats, Wistar; Reproducibility of Results; Spinal Cord; Time Factors; Vildagliptin

2011
Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.
    British journal of pharmacology, 2012, Volume: 165, Issue:2

    Topics: Adamantane; Analgesics, Opioid; Animals; Behavior, Animal; Conditioning, Classical; Dipeptides; Drug Tolerance; Fentanyl; Hot Temperature; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pain; Receptors, Neuropeptide; Substance Withdrawal Syndrome

2012
RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Jan-10, Volume: 103, Issue:2

    Topics: Adamantane; Amides; Analgesics, Opioid; Animals; Blood Pressure; Chlorocebus aethiops; COS Cells; Dipeptides; Drug Tolerance; Heart Rate; Heroin; Humans; Hyperalgesia; Ligands; Molecular Structure; Rats; Receptors, Neuropeptide

2006